{"transactions":[{"id":3696304,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer, EVP"}}],"security":"Restricted Stock Units","published_at":"2019-01-15T02:49:30.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":816634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Vital Therapies, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), twenty five percent (25%) of the RSUs vest annually after the vesting commencement date of January 11, 2019.   One hundred percent (100%) of the unvested portion of the RSUs, if any, shall vest in the event of a Termination without Cause or Resignation for Good Reason (each as defined in the reporting person's Change of Control and Severance Agreement)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), twenty five percent (25%) of the RSUs vest annually after the vesting commencement date of January 11, 2019.   One hundred percent (100%) of the unvested portion of the RSUs, if any, shall vest in the event of a Termination without Cause or Resignation for Good Reason (each as defined in the reporting person's Change of Control and Severance Agreement)."}],"balance_after":816634,"derivative":{"underlying":"Common Stock","underlying_shares":816634},"source":{"system":"sec-edgar","filing":"0001280776-19-000017","document":"wf-form4_154752054652794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000017/wf-form4_154752054652794.xml","form_type":"4"}},{"id":3696303,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer, EVP"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-15T02:49:30.000Z","date":"2019-01-11","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc.  The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the \"Plan\")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of June 9, 2018, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter.  One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan)."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001280776-19-000017","document":"wf-form4_154752054652794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000017/wf-form4_154752054652794.xml","form_type":"4"}},{"id":3696302,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer, EVP"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-15T02:49:30.000Z","date":"2019-01-11","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc.  The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the \"Plan\")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of June 10, 2017, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter.  One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan)."}],"balance_after":0,"derivative":{"exercise_price":3.2,"expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001280776-19-000017","document":"wf-form4_154752054652794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000017/wf-form4_154752054652794.xml","form_type":"4"}},{"id":3696301,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer, EVP"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-15T02:49:30.000Z","date":"2019-01-11","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc.  The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the \"Plan\")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of April 16, 2016, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter.  One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan)."}],"balance_after":0,"derivative":{"exercise_price":8.28,"expiration_date":"2026-05-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001280776-19-000017","document":"wf-form4_154752054652794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000017/wf-form4_154752054652794.xml","form_type":"4"}},{"id":3696300,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer, EVP"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-15T02:49:30.000Z","date":"2019-01-11","kind":"disposition_to_issuer","acquired":false,"shares":241670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc.  The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation."}],"balance_after":0,"derivative":{"exercise_price":8,"exercise_date":"2016-09-13","expiration_date":"2022-09-25","underlying":"Common Stock","underlying_shares":241670},"source":{"system":"sec-edgar","filing":"0001280776-19-000017","document":"wf-form4_154752054652794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000017/wf-form4_154752054652794.xml","form_type":"4"}},{"id":3696299,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer, EVP"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-15T02:49:30.000Z","date":"2019-01-11","kind":"disposition_to_issuer","acquired":false,"shares":23344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc.  The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.4284,"exercise_date":"2016-04-25","expiration_date":"2022-04-24","underlying":"Common Stock","underlying_shares":23344},"source":{"system":"sec-edgar","filing":"0001280776-19-000017","document":"wf-form4_154752054652794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000017/wf-form4_154752054652794.xml","form_type":"4"}},{"id":3696298,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer, EVP"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-15T02:49:30.000Z","date":"2019-01-11","kind":"disposition_to_issuer","acquired":false,"shares":93377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc.  The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation."}],"balance_after":0,"derivative":{"exercise_price":0.4284,"exercise_date":"2016-02-08","expiration_date":"2022-03-31","underlying":"Common Stock","underlying_shares":93377},"source":{"system":"sec-edgar","filing":"0001280776-19-000017","document":"wf-form4_154752054652794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000017/wf-form4_154752054652794.xml","form_type":"4"}},{"id":3898229,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer, EVP"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-11T23:23:21.000Z","date":"2018-06-09","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares of common stock subject to the option shall vest monthly beginning on July 9, 2018, such that all of the shares of common stock subject to the option are vested by June 9, 2022, subject to the reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the \"Plan\")) through each vesting date; provided, that, 100% of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan)."}],"balance_after":75000,"derivative":{"exercise_price":5,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001280776-18-000071","document":"wf-form4_152875938337968.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077618000071/wf-form4_152875938337968.xml","form_type":"4"}},{"id":4283447,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer, EVP"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T00:06:35.000Z","date":"2017-06-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares of common stock subject to the option shall vest monthly beginning on July 10, 2017, such that all of the shares of common stock subject to the option are vested by June 10, 2021, subject to the reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the \"Plan\")) through each vesting date; provided, that, 100% of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan)."}],"balance_after":75000,"derivative":{"exercise_price":3.2,"expiration_date":"2027-06-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001280776-17-000063","document":"wf-form4_149739877852679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077617000063/wf-form4_149739877852679.xml","form_type":"4"}},{"id":4283446,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":161067,"kind":"person","name":"Ashley Robert A.","position":1,"cik":"0001591017","reported_name":"Ashley Robert A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer, EVP"}}],"security":"Common Stock","published_at":"2017-06-14T00:05:03.000Z","date":"2017-06-09","kind":"purchase","acquired":true,"shares":2000,"price":3.18,"value":6360.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001280776-17-000062","document":"wf-form4_149739868678115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077617000062/wf-form4_149739868678115.xml","form_type":"4"}}]}